Abstract:Abstract Genomic instability is the hallmark of various cancers with the increasing accumulation of DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is typically based on this property of cancers. However, the adverse effects including normal tissues injury are also accompanied by the radiotherapy and chemotherapy. Targeted cancer therapy has the potential to suppress cancer cells’ DNA damage response through tailoring therapy to cancer patients lacking specific DNA damage response functions. Obviously, understanding the broader role of DNA damage repair in cancers has became a basic and attractive strategy for targeted cancer therapy, in particular, raising novel hypothesis or theory in this field on the basis of previous scientists’ findings would be important for future promising druggable emerging targets. In this review, we first illustrate the timeline steps for the understanding the roles of DNA damage repair in the promotion of cancer and cancer therapy developed, then we summarize the mechanisms regarding DNA damage repair associated with targeted cancer therapy, highlighting the specific proteins behind targeting DNA damage repair that initiate functioning abnormally duo to extrinsic harm by environmental DNA damage factors, also, the DNA damage baseline drift leads to the harmful intrinsic targeted cancer therapy. In addition, clinical therapeutic drugs for DNA damage and repair including therapeutic effects, as well as the strategy and scheme of relative clinical trials were intensive discussed. Based on this background, we suggest two hypotheses, namely “environmental gear selection” to describe DNA damage repair pathway evolution, and “DNA damage baseline drift”, which may play a magnified role in mediating repair during cancer treatment. This two new hypothesis would shed new light on targeted cancer therapy, provide a much better or more comprehensive holistic view and also promote the development of new research direction and new overcoming strategies for patients.

The DNA damage-induced cell death response: a roadmap to kill cancer cells

DNA damage and the balance between survival and death in cancer biology

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

The DNA damage response: putting checkpoints in perspective

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy

DNA Damage and Its Role in Cancer Therapeutics

A Molecular Dynamics of Radiation-Induced DNA Damage Response: Exploring the Pathways of Signaling, Repair, and Cell Death

DNA Damage Checkpoint Recovery and Cancer Development

Targeting DNA damage response pathways in cancer

Activation of DNA damage response signaling in mammalian cells by ionizing radiation

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity

Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Cell death pathways: molecular mechanisms and therapeutic targets for cancer

Cell death pathways: intricate connections and disease implications

A comprehensive review of sensors of radiation‐induced damage, radiation‐induced proximal events, and cell death

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities

Research progress in DNA damage checkpoint mechanism